Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Otocap (also marketed as Otocap VT) is an oral nutraceutical supplement developed by Centaur Pharmaceuticals. It is formulated as a capsule containing a combination of active ingredients, including alpha lipoic acid, ginkgo biloba extract, methylcobalamin, chromium picolinate, zinc, magnesium, vitamin B6, vitamin C, and vitamin E. Otocap is primarily indicated to support nerve health and auditory function in patients suffering from conditions such as tinnitus, vertigo, Meniere's disease, and sensorineural hearing loss. The supplement works by improving microcirculation to the inner ear and providing robust antioxidant protection against free radical-induced cellular damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Otocap.